What is an intraocular contact lens (IPCL) and how does it correct vision?

An intraocular contact lens, also known as IPCL, is a treatment method that corrects myopia and astigmatism by inserting a small lens into the eye. It utilizes an acrylic polymer material, primarily HEMA, which is also used in cataract intraocular lenses and contact lenses.

What are the key advantages of IPCL compared to LASIK?

A significant advantage of IPCL over LASIK is that it does not involve shaving the cornea. This makes it a highly reversible treatment method, as the lens can be removed in the future if necessary.

When did IPCL receive approval and launch in Japan?

IPCL obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan in April 2025, following multi-center clinical trials. It was subsequently launched in September of the same year.

What is the target demographic for the awareness survey on intraocular contact lenses?

The awareness survey on intraocular contact lenses was conducted among men and women nationwide, aged between their 20s and 40s, who have a vision of 0.1 or less.

What percentage of survey respondents were aware of intraocular contact lenses as a treatment method?

Regarding the treatment method of intraocular contact lenses, over 70% of the survey subjects, specifically 72.8%, reported being aware of it.

AI News NQ Analysis

Awareness Survey on Intraocular Contact Lenses (Phakic Posterior Chamber Lenses) for Men and Women in their 20s to 40s with Vision of 0.1 or Less

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is an intraocular contact lens (IPCL) and how does it correct vision?: A: An intraocular contact lens, also known as IPCL, is a treatment method that corrects myopia and astigmatism by inserting a small lens into the eye. It utilizes an acrylic polymer material, primarily HEMA, which is also used in cataract intraocular lenses and contact lenses.
Q: What are the key advantages of IPCL compared to LASIK?: A: A significant advantage of IPCL over LASIK is that it does not involve shaving the cornea. This makes it a highly reversible treatment method, as the lens can be removed in the future if necessary.
Q: When did IPCL receive approval and launch in Japan?: A: IPCL obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan in April 2025, following multi-center clinical trials. It was subsequently launched in September of the same year.
Q: What is the target demographic for the awareness survey on intraocular contact lenses?: A: The awareness survey on intraocular contact lenses was conducted among men and women nationwide, aged between their 20s and 40s, who have a vision of 0.1 or less.
Q: What percentage of survey respondents were aware of intraocular contact lenses as a treatment method?: A: Regarding the treatment method of intraocular contact lenses, over 70% of the survey subjects, specifically 72.8%, reported being aware of it.